Published on 27/01/2014
A compound designed to help prevent the spread of breast cancer has been developed by researchers at Cardiff University.
Successful trials were made on mice
The treatment aims to stop the spread of breast cancer reaching other parts of the body and preventing the onset of metastasis. Metastasis is the spread of a cancer to another organ and treatment or survival is sometimes dependent on whether or not cancer spreads or remains localised.
Cardiff University hope to develop a compound that will reverse the spread of malignant breast cancer to other vital organs such as the lung. Many cancers become fatal once the spread has happened and is responsible for the majority of deaths from the disease.
The research was performed on mice and found that there was a complete halt in the spreading of metastatic tumours if the compound was taken.
The compound works by inhibiting the specific gene that causes metastatic breast cancer and is essential for it to function. The gene is known as Bc13 and with the help of computer-aided modelling scientists have found a way to stop this gene working in mice.
Clinical trials are the next step for the compound and experts believe research like this is vitally important to increase growing cancer survival rates.
Dr Richard Clarkson from the University’s European Cancer Stem Cell Research Institute said: “Despite great improvements in therapy of early stage breast cancer, the current therapeutic options for patients with late stage metastatic disease are limited.
“There is therefore a clear unmet clinical need to identify new drugs to reverse or at least to slow down disease progression.”
Private health insurance can cover you or your family for cancer treatment and can give you access to the latest drugs and therapies not always readily available on the NHS.
© ActiveQuote Ltd. 2014Categories: Health Insurance